69 related articles for article (PubMed ID: 15595638)
1. C-MYB, serum P-53M, genetic instability, labeling index and endoscopic findings in patients with adenoma or colorectal cancer.
Assisi D; Grassi A; La Penta R; Stigliano V; Greco C; Cianciulli AM; Giannarelli D; Casale V
J Exp Clin Cancer Res; 2004 Sep; 23(3):469-75. PubMed ID: 15595638
[TBL] [Abstract][Full Text] [Related]
2. Detection of C-myb genetic alterations and mutant p53 serum protein in patients with benign and malignant colon lesions.
Greco C; Gandolfo GM; Mattei F; Gradilone A; Alvino S; Pastore LI; Casale V; Casole P; Grassi A; Cianciulli AM
Anticancer Res; 1994; 14(3B):1433-40. PubMed ID: 8067719
[TBL] [Abstract][Full Text] [Related]
3. Serum macrophage-colony stimulating factor levels in colorectal cancer patients correlate with lymph node metastasis and poor prognosis.
Mroczko B; Groblewska M; Wereszczyńska-Siemiatkowska U; Okulczyk B; Kedra B; Łaszewicz W; Dabrowski A; Szmitkowski M
Clin Chim Acta; 2007 May; 380(1-2):208-12. PubMed ID: 17368603
[TBL] [Abstract][Full Text] [Related]
4. Detection of cancer clones in human colorectal adenoma as revealed by increased DNA instability and other bio-markers.
Jin Y; Sun A; Noriki S; Imamura Y; Fukuda M
Eur J Histochem; 2007; 51(1):1-10. PubMed ID: 17548263
[TBL] [Abstract][Full Text] [Related]
5. A high degree of aneuploidy, loss of p53 gene, and low soluble p53 protein serum levels are detected in ulcerative colitis patients.
Rosman-Urbach M; Niv Y; Birk Y; Smirnoff P; Zusman I; Morgenstern S; Schwartz B
Dis Colon Rectum; 2004 Mar; 47(3):304-13. PubMed ID: 14991492
[TBL] [Abstract][Full Text] [Related]
6. P53 correlates positively with VEGF in preoperative sera of colorectal cancer patients.
Famulski W; Sulkowska M; Wincewicz A; Kedra B; Pawlak K; Zalewski B; Sulkowski S; Koda M; Baltaziak M
Neoplasma; 2006; 53(1):43-8. PubMed ID: 16416012
[TBL] [Abstract][Full Text] [Related]
7. [IL-6, p53 and proto-oncogene c-myc play different roles as biological markers of plasma cell dyscrasias].
Alvino S; Marcucci M; Canzoniere D; Mosiello A; Del Monte G; Venturo I; Rinaldi M; Gandolfo GM; Lopez M; Greco C
Clin Ter; 1999; 150(3):197-202. PubMed ID: 10528431
[TBL] [Abstract][Full Text] [Related]
8. APC, K-ras, and p53 gene mutations in colorectal cancer patients: correlation to clinicopathologic features and postoperative surveillance.
Hsieh JS; Lin SR; Chang MY; Chen FM; Lu CY; Huang TJ; Huang YS; Huang CJ; Wang JY
Am Surg; 2005 Apr; 71(4):336-43. PubMed ID: 15943410
[TBL] [Abstract][Full Text] [Related]
9. Epithelial and stromal genetic instability contributes to genesis of colorectal adenomas.
Ishiguro K; Yoshida T; Yagishita H; Numata Y; Okayasu T
Gut; 2006 May; 55(5):695-702. PubMed ID: 16354798
[TBL] [Abstract][Full Text] [Related]
10. Chromosomal changes in colorectal adenomas: relationship to gene mutations and potential for clinical utility.
Leslie A; Stewart A; Baty DU; Mechan D; McGreavey L; Smith G; Wolf CR; Sales M; Pratt NR; Steele RJ; Carey FA
Genes Chromosomes Cancer; 2006 Feb; 45(2):126-35. PubMed ID: 16235243
[TBL] [Abstract][Full Text] [Related]
11. Mutant plasma p53 protein levels: prognostication in colorectal carcinoma.
Wong SK; Seow-Choen F; Leong AP; Ho YH; Aw SE
Br J Surg; 1997 May; 84(5):664-5. PubMed ID: 9171756
[No Abstract] [Full Text] [Related]
12. Comparative analysis of predictive biomarkers for therapeutical strategies in colorectal cancer.
Gasser M; Gerstlauer C; Grimm M; Bueter M; Lebedeva T; Lutz J; Maeder U; Ribas C; Ribas C; Nichiporuk E; Thalheimer A; Heemann U; Thiede A; Meyer D; Waaga-Gasser AM
Ann Surg Oncol; 2007 Apr; 14(4):1272-84. PubMed ID: 17211733
[TBL] [Abstract][Full Text] [Related]
13. [Serum concentration of insulin, C-peptide and insulin-like growth factor I in patients with colon adenomas and colorectal cancer].
Kaczka A; Kumor A; Pietruczuk M; Małecka-Panas E
Pol Merkur Lekarski; 2007 May; 22(131):373-5. PubMed ID: 17679371
[TBL] [Abstract][Full Text] [Related]
14. Mutant p53 protein in the serum of patients with colorectal cancer: Correlation with the level of carcinoembryonic antigen and serum epidermal growth factor receptor.
Abdel-Aziz MM; Lotfy M; El-Kady IM; Abozaid M
Cancer Detect Prev; 2009; 32(4):329-35. PubMed ID: 16632243
[TBL] [Abstract][Full Text] [Related]
15. Serum p53 antibody as tumor marker for follow-up of colorectal cancer after curative resection.
Tang R; Yeh CY; Wang JY; Changchien CR; Chen JS; Hsieh LL
Ann Surg Oncol; 2009 Sep; 16(9):2516-23. PubMed ID: 19565285
[TBL] [Abstract][Full Text] [Related]
16. Loss of programmed cell death 4 expression marks adenoma-carcinoma transition, correlates inversely with phosphorylated protein kinase B, and is an independent prognostic factor in resected colorectal cancer.
Mudduluru G; Medved F; Grobholz R; Jost C; Gruber A; Leupold JH; Post S; Jansen A; Colburn NH; Allgayer H
Cancer; 2007 Oct; 110(8):1697-707. PubMed ID: 17849461
[TBL] [Abstract][Full Text] [Related]
17. Rectal aberrant crypt foci identified using high-magnification-chromoscopic colonoscopy: biomarkers for flat and depressed neoplasia.
Hurlstone DP; Karajeh M; Sanders DS; Drew SK; Cross SS
Am J Gastroenterol; 2005 Jun; 100(6):1283-9. PubMed ID: 15929758
[TBL] [Abstract][Full Text] [Related]
18. Association of serum lipids and apolipoprotein E gene polymorphism with the risk of colorectal adenomas.
Zhongyin Z; Hesheng L; Jun L; Jihong C
Saudi Med J; 2006 Feb; 27(2):161-4. PubMed ID: 16501668
[TBL] [Abstract][Full Text] [Related]
19. Flat elevated lesions of the colon and rectum: a spectrum of neoplastic and nonneoplastic entities.
Gualco G; Reissenweber N; Cliché I; Bacchi CE
Ann Diagn Pathol; 2006 Dec; 10(6):333-8. PubMed ID: 17126250
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical characteristics of duodenal adenomas in familial adenomatous polyposis with special reference to cell kinetics.
Esaki M; Matsumoto T; Yao S; Nakamura S; Hirahashi M; Yao T; Iida M
Hum Pathol; 2005 Jan; 36(1):66-73. PubMed ID: 15712184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
